Delivery Order SPE2DB22D1106-SPE2DB25FFJH6
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $25,338.10 firm fixed-price delivery order from the Defense Logistics Agency on September 15, 2025, for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccines. This is a non-set-aside competitive award with an ultimate completion date of September 16, 2025, and performance will occur at the company's Conshohocken, PA facility. The delivery order is issued as a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $45K on July 23, 2025, for the supply of Menveo vaccine (5-dose vials). This competitively awarded, firm fixed-price delivery order is expected to be completed by July 24, 2025, and will be performed at the contractor's Conshohocken facility. The award was funded by the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,375.92 for the Menveo vaccine (5-dose vial) by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $34,059.20 on August 29, 2025, for supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency Medical Supply Chain, a defense agency component, with an ultimate completion date of September 2, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,007.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials each). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $262,572.45 delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products. The contract, with a completion date of July 23, 2025, represents a competitive, non-set-aside award utilizing firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a $24,637.20 delivery order by the Defense Logistics Agency (DLA) for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 22, 2025, and will be performed at the company's Conshohocken location. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger prime...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135-diphtheria), 0.5 mL. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,159.30 and is scheduled for completion by August 13, 2025. The award is issued under a non-set-aside procurement and represents a child contract action...
- The Defense Logistics Agency awarded a $2,138.48 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical procurement under the company's existing relationship with the federal government's medical...
- The Defense Logistics Agency awarded a $2,014.32 delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is due for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this delivery is executed under AmerisourceBergen's larger Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFJH6Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $13,616.96 firm fixed-price delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). The contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. Performance will be completed at the company's Conshohocken, Pennsylvania facility by the ultimate completion date of September 18, 2025. This delivery order supports the Defense Health Agency's pharmaceutical supply chain requirements and reflects AmerisourceBergen's established role as a critical vendor for federal military and defense healthcare systems. The award demonstrates the company's continued participation in the DLA's comprehensive pharmaceutical prime vendor program, which enables the delivery of specialized medical commodities, vaccines, and medications to support military healthcare operations globally. The meningococcal vaccine supply under this contract supports immunization needs within the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 9/17/25 |